Show simple item record

dc.contributor.authorLavery, JV
dc.contributor.authorSinger, PA
dc.contributor.authorRidzon, R
dc.contributor.authorSingh, JA
dc.contributor.authorSlutsky, AS
dc.contributor.authorAnisko, JJ
dc.contributor.authorBuchanan, D
dc.date.accessioned2020-12-17T03:52:48Z
dc.date.available2020-12-17T03:52:48Z
dc.date.issued2009-06-01
dc.identifier.citationLavery, J. V., Singer, P. A., Ridzon, R., Singh, J. A., Slutsky, A. S., Anisko, J. J. & Buchanan, D. (2009). In Global Health Research, Is It Legitimate To Stop Clinical Trials Early on Account of Their Opportunity Costs?. PLOS MEDICINE, 6 (6), https://doi.org/10.1371/journal.pmed.1000071.
dc.identifier.issn1549-1277
dc.identifier.urihttp://hdl.handle.net/11343/255071
dc.description.abstractBACKGROUND TO THE DEBATE: After the failure of three large clinical trials of vaginal microbicides, a Nature editorial stated that the microbicide field "requires a mechanism to help it make rational choices about the best candidates to move through trials" [1]. In this month's debate, James Lavery and colleagues propose a new mechanism, based on stopping trials early for "opportunity costs." They argue that microbicide trial sites could have been saturated with trials of scientifically less advanced products, while newer, and potentially more promising, products were being developed. They propose a mechanism to reallocate resources invested in existing trials of older products that might be better invested in more scientifically advanced products that are awaiting clinical testing. But David Buchanan argues that the early stopping of trials for such opportunity costs would face insurmountable practical barriers, and would risk causing harm to the participants in the trial that was stopped.
dc.languageEnglish
dc.publisherPUBLIC LIBRARY SCIENCE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleIn Global Health Research, Is It Legitimate To Stop Clinical Trials Early on Account of Their Opportunity Costs?
dc.typeJournal Article
dc.identifier.doi10.1371/journal.pmed.1000071
melbourne.affiliation.departmentSchool of Historical and Philosophical Studies
melbourne.source.titlePLoS Medicine
melbourne.source.volume6
melbourne.source.issue6
dc.rights.licenseCC BY
melbourne.elementsid1232317
melbourne.contributor.authorSinger, Peter
dc.identifier.eissn1549-1676
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record